Beem blue, red, and infrared light therapy for healthier-looking skin
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
Try a twice-weekly, 20-minute blue, red, and infrared light therapy to see if it improves skin health in eligible U.S. residents.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Efforia, Inc Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT07298382 on ClinicalTrials.gov |
What this trial studies
This single-arm, observational Signal Phase study has participants undergo two 20-minute light therapy sessions per week at Efforia in New York City. Each session is divided into blue, red, and infrared phases designed to target different aspects of skin health. Participants complete weekly skin self-assessments, the Dermatology Life Quality Index, a facial skin survey, and pre- and post-study photos to measure changes. The design uses participants as their own control to gather preliminary safety and efficacy data on skin appearance and patient-reported outcomes.
Who should consider this trial
Good fit: Ideal candidates are U.S. residents who can read English, can attend twice-weekly in-person sessions at the New York site, and do not meet any exclusion criteria such as photosensitivity.
Not a fit: People with epilepsy, photosensitivity, eye conditions, pregnancy, skin sensitivity, or those taking photosensitizing medications are excluded and thus not expected to benefit from this protocol.
Why it matters
Potential benefit: If successful, the therapy could provide a convenient, noninvasive option to improve skin appearance and boost natural glow.
How similar studies have performed: Previous studies of red and near-infrared light have shown benefits for skin rejuvenation and acne, while combined blue/red/infrared protocols have some supporting evidence but remain less extensively studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with Epilepsy * Individuals with Photosensitivity * Individuals with eye conditions * Pregnant individuals * Individuals with skin sensitivity * Individuals taking certain light-sensitive medications
Where this trial is running
New York, New York
- Efforia — New York, New York, United States (Recruiting)
Study contacts
- Study coordinator: Matthew Amsden
- Email: help@efforia.com
- Phone: (646) 679-2479
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.